Obstetrics/Gynecology
RSSArticles
-
FDA Move Widens Approved Use of Human Papillomavirus Vaccine
The Food and Drug Administration has approved the use of the nine-valent human papillomavirus (HPV) vaccine in women and men ages 27-45. The Advisory Committee on Immunization Practices (ACIP) is scheduled to review further information at its February 2019 meeting, with a potential vote at that time. Insurance reimbursement often is based on ACIP guidance.
-
With Reclassification and New Name, Doors May Open for Internal Condom
The Food and Drug Administration has reclassified the female condom from a Class III device to a Class II device, putting it in the same category as the male condom.
-
Acupuncture as Adjunct Therapy for Infertility in Polycystic Ovary Syndrome
Acupuncture as an adjunctive therapy for treating infertility in Chinese women with polycystic ovary syndrome receiving clomiphene citrate or placebo offered no benefit over sham acupuncture.
-
Venous Thromboembolism Risk After Abortion
Women experience a two-fold increase in risk of venous thrombosis (relative to nonpregnant women) following induced abortion, but a more than six-fold overall reduction in risk of thrombosis compared to women who continue the pregnancy to term.
-
Help-seeking Behavior for Pelvic Floor Dysfunction
Women are more likely to seek help for pelvic floor symptoms if they have increased bother and are less likely to seek help if they perceive their symptoms as normal.
-
Opportunistic Salpingectomy at the Time of Cesarean Delivery for Postpartum Permanent Contraception
In this retrospective cohort study, almost 20% of women who desired bilateral complete salpingectomy for permanent contraception at the time of cesarean delivery could not undergo the procedure because of adhesions or engorged vasculature.
-
Are There Risks With Early-term Birth?
The authors of a multicenter study suggest that composite neonatal outcome is worse when pregnancy is interrupted in uncomplicated pregnancies at 37 to 38 weeks, even with documented fetal lung maturity, compared to pregnancies delivered at full term (39 to 40 weeks).
-
Eliminate Barriers to Expedited Partner Therapy
Since 2006, the Centers of Disease Control and Prevention has recommended the use of expedited partner therapy (EPT) for treatment of sexually transmitted infections such as gonorrhea and chlamydia, but the infection rate continues to climb.
-
What Can Clinicians Do to Combat Increase in Congenital Syphilis Rates?
Cases of congenital syphilis have more than doubled since 2013, according to the Centers for Disease Control and Prevention. All pregnant women should visit a healthcare provider as soon as possible to be tested for syphilis, but one test may not be enough to catch all cases.
-
Abortion Access in the United States: Adolescents and Women of Color Face Increased Barriers
When accessing reproductive health services, particularly abortion, young people face additional barriers, such as cost, stigma, confidentiality, and privacy concerns.